We are live on ! Find out more
EDSA icon

Edesa Biotech

15 hedge funds and large institutions have $774K invested in Edesa Biotech in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

25% more funds holding

Funds holding: 12 → 15 (+3)

0.95% less ownership

Funds ownership: 2.04% → 1.09% (-0.95%)

20% less capital inflows, than outflows

Capital inflows: $580K | Capital outflows: $729K

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

EDSA Hedge Fund Activity: Q1 2021 in Review

15 of the 5,714 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q1 2021, worth a combined $774K — down 15% from $910K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new EDSA positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $223K. The largest seller was FNY Investment Advisers, exiting entirely with an estimated $318K sold.

  • 15 institutional investors held Edesa Biotech (EDSA) as of Q1 2021, up from 12 in Q4 2020.
  • Funds reported $774K of Edesa Biotech stock for Q1 2021, down 15% quarter-over-quarter.
  • 6 funds opened new Edesa Biotech positions in Q1 2021 and 3 closed out, a net change of +3 holders.
  • The largest Edesa Biotech buyer in Q1 2021 was Vanguard Group, an estimated $223K added.
  • The largest Edesa Biotech seller in Q1 2021 was FNY Investment Advisers, an estimated $318K sold.

Based on aggregated 13F filings for Q1 2021.